儿童胶质瘤早期死亡预测因素:基于SEER数据库的分析
该研究利用SEER数据库纳入3035例男性与2741例女性儿童胶质瘤患者,采用逻辑回归分析早期死亡的独立预测因素。诊断后1个月和3个月死亡率分别为1.32%和2.44%,过去40年早期死亡率显著下降;胶质母细胞瘤、间变性胶质瘤和少突胶质瘤为早期死亡危险因素,而高龄、全切除、放疗和化疗与早期死亡降低相关。
要点
- 儿童胶质瘤诊断后1个月和3个月死亡率分别为1.32%和2.44%。
- 胶质母细胞瘤、间变性胶质瘤和少突胶质瘤是早期死亡危险因素。
- 高龄、全切除、放疗和化疗与早期死亡降低相关。
核心结论
- 过去40年儿童胶质瘤早期死亡率显著下降。
- 诊断年龄、组织学亚型、切除范围、化疗和放疗与儿童胶质瘤早期死亡相关。
研究设计与样本
- 回顾性队列研究,数据来源于SEER数据库,使用SEER*Stat 8.3.5软件提取。
- 共纳入3035例男性与2741例女性儿童胶质瘤患者。
- 采用逻辑回归分析识别早期死亡的独立预测因素。
主要发现
- 诊断后1个月内死亡率为1.32%,3个月内死亡率为2.44%。
- 胶质母细胞瘤、间变性胶质瘤和少突胶质瘤是早期死亡的危险因素。
- 高龄、全切除、放疗和化疗与早期死亡降低相关。
临床怎么用
- 对于儿童胶质瘤患者,应关注组织学亚型以识别早期死亡高风险人群。
- 全切除、放疗和化疗与降低早期死亡相关,可作为治疗策略参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the early mortality in pediatric glioma and identify predictors of early mortality, which may provide insight into the therapeutic strategies for children with a high risk of early mortality. METHODS: We used SEER∗Stat 8.3.5 software to extract data of pediatric glioma from the Surveillance, Epidemiology, and End Results database. Logistical regression to identify the independent factors in predicting early mortality. RESULTS: A total of 3035 male and 2741 female patients were enrolled in the present study. The death rates within 1 month and 3 months after diagnosis were 1.32% and 2.44%, respectively. Early mortality decreased significantly during the past 40 years. Our results showed that glioblastoma, anaplastic glioma, and oligodendroglioma were risk factors of early mortality for children diagnosed with glioma, whereas advanced age, gross total resection, radiation, and chemotherapy were associated with decreased early mortality. CONCLUSIONS: We found a decrease in early mortality during the past 40 years. The death rates within 1 month and 3 months after diagnosis were 1.32% and 2.44%, respectively. Age at diagnosis, histologic subtype, the extent of resection, chemotherapy, and radiation were associated with early mortality in pediatric glioma.
引用
- Zhou X, Niu X, Sun K, et al. Pediatric Glioma Outcomes: Predictors of Early Mortality. World Neurosurg. 2020. PMID: 32389863. doi:10.1016/j.wneu.2020.04.107
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。